Single peptide Vial strength 10 mg
Sermorelin10 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Sermorelin, explained simply
A GHRH analogue that acts on pituitary growth hormone release, with different evidence according to age and indication.
Research area
Growth hormone axis
How it works
Sermorelin is a GHRH analogue that stimulates endogenous growth hormone release.
Why it matters
It helps explain the difference between stimulating the pituitary and administering growth hormone directly.
What has been observed
Studies on GH secretion and IGF-1 are reported in distinct pediatric and adult settings.
Effects and points to consider
Age, indication, and formulation affect how the evidence is interpreted; findings in one setting do not confirm other uses.
01 / Vial strength 10 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 10 mg Sermorelin |
|---|---|
| Final volume | 3 mL |
| Concentration | 3.33 mg/mL |
| One U-100 unit | 33.33 mcg in 0.01 mL |
Standard / Gradual Approach (3 mL = ~3.33 mg/mL)
| Week | Daily Dose (µg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 200 µg (0.2 mg) | 6 units (0.06 mL) |
| Weeks 3–4 | 300 µg (0.3 mg) | 9 units (0.09 mL) |
| Weeks 5–6 | 400 µg (0.4 mg) | 12 units (0.12 mL) |
| Weeks 7–8 | 500 µg (0.5 mg) | 15 units (0.15 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.